Digital health and AI empowerment By monitoring patients' energy metabolism indicators such as blood glucose, heart rate variability, and activity levels through wearable devices, combined with AI algorithms to achieve dynamic dose adjustment and personalized treatment recommendations, the "central planning" intervention efficiency of GLP-1RA can be improved
The NHS currently commissions other options (for example, semaglutide and Tirzepatide for eligible groups) under NICE guidance
C., Bell-Anderson, K., Kebede, M., Yau, B., Atkinson, C., Svineng, G., Dodgson, T., Wali, J
Bone 24:195202 Sever M, Klicek R, Radic B, Brcic L, Zoricic I, Drmic D, Ivica M, Barisic I, Ilic S, Berkopic L, Blagaic AB (2009) Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats
Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, Poumbourios P, et al